Your browser doesn't support javascript.
loading
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia.
El-Jawahri, Areej; Li, Shuli; Ballen, Karen K; Cutler, Corey; Dey, Bimalangshu R; Driscoll, Jessica; Hunnewell, Chrisa; Ho, Vincent T; McAfee, Steven L; Poliquin, Cathleen; Saylor, Meredith; Soiffer, Robert J; Spitzer, Thomas R; Alyea, Edwin; Chen, Yi-Bin.
Afiliação
  • El-Jawahri A; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Li S; Division of Computational Biology and Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ballen KK; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Cutler C; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Dey BR; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Driscoll J; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Hunnewell C; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Ho VT; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McAfee SL; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Poliquin C; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Saylor M; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Soiffer RJ; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Spitzer TR; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Alyea E; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chen YB; Bone Marrow Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ychen6@partners.org.
Biol Blood Marrow Transplant ; 22(1): 80-5, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26260679
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Bussulfano / Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Condicionamento Pré-Transplante / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Bussulfano / Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Condicionamento Pré-Transplante / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2016 Tipo de documento: Article